Skip Navigation

Cardiovascular Research 1997 34(1):91-98; doi:10.1016/S0008-6363(97)00034-5
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yu, J. Z
Right arrow Articles by McNeill, J. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, J. Z
Right arrow Articles by McNeill, J. H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Intracellular calcium levels are unchanged in the diabetic heart

Jen Z Yua, Brian Rodriguesb and John H McNeillb,*

aCardiovascular Research Laboratory, Department of Pathology and Laboratory Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada
bDivision of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada

* Corresponding author. Tel. +1 604 822-9373; Fax +1 604 822-8001.

Received 24 October 1996; accepted 9 January 1997

KEYWORDS Diabetes; Cardiomyopathy; Calcium, intracellular concentration; SR, calcium release

The first 150 words of the full text of this article appear below.


    1 Introduction
 
Diabetes mellitus has been associated with cardiac disease that has been suggested to occur secondary to atherosclerosis of the coronary arteries, macroangiopathy and autonomic neuropathy [1]. However, a cardiac disease particular to diabetes has also been demonstrated to occur in the absence of the above factors. This ‘diabetic cardiomyopathy’ that includes cardiomegaly, left ventricular dysfunction and clinically overt congestive heart failure has been strongly suggested by epidemiological, clinical and experimental studies [2–7]. The etiology of diabetic cardiomyopathy is complex and a number of factors have been suggested to be involved in the development of this disease state. These include: (a) changes in cardiac metabolism, (b) abnormal vascular sensitivity and reactivity to various ligands, (c) increased stiffness of the ventricular wall associated with perivascular thickening of basement membrane and interstitial accumulation of glycoprotein and insoluble collagen, and (d) abnormalities of various proteins which control ion movements, specifically intracellular calcium . . . [Full Text of this Article]


    2 [Ca2+]i mobilization in ventricular myocytes
 

    3 Intracellular Ca2+ in the diabetic heart
 

    4 [Ca2+] mobilization in the diabetic heart
 
4.1 Sarcolemmal Ca2+ channels and Ca2+ and K+ currents in diabetic cardiomyocytes
4.2 Na–Ca exchange activity in SL of diabetic myocardium
4.3 SR Ca2+-ATPase in diabetic cardiomyocytes
4.3.1 Rapid-cooling and caffeine contractures
4.3.2 Caffeine-induced calcium transients in quiescent myocytes
4.4 Mitochondrial function in diabetic hearts
4.5 Myofilaments and Ca2+ sensitivity in diabetic cardiomyocytes
4.6 [Ca2+]i responses to β-adrenergic stimulation
4.7 [Ca2+]i responses to different pharmacological agents
4.7.1 Isoproterenol and 8-bromo-cAMP
4.7.2 Ouabain
4.7.3 KCl and ATP

    5 Summary
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
L. Zhang, M. B. Cannell, A. R.J. Phillips, G. J.S. Cooper, and M.-L. Ward
Altered Calcium Homeostasis Does Not Explain the Contractile Deficit of Diabetic Cardiomyopathy
Diabetes, August 1, 2008; 57(8): 2158 - 2166.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Ayaz and B. Turan
Selenium prevents diabetes-induced alterations in [Zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1071 - H1080.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Li, I. G. Obrosova, O. Abatan, D. Tian, D. Larkin, E. L. Stuenkel, and M. J. Stevens
Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E29 - E36.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. M. Choi, Y. Zhong, B. D. Hoit, I. L. Grupp, H. Hahn, K. W. Dilly, S. Guatimosim, W. J. Lederer, and M. A. Matlib
Defective intracellular Ca2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1398 - H1408.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Abe, Y. Ohga, N. Tabayashi, S. Kobayashi, S. Sakata, H. Misawa, T. Tsuji, H. Kohzuki, H. Suga, S. Taniguchi, et al.
Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats
Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H138 - H148.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Kotsanas, L. M. Delbridge, and I. R Wendt
Stimulus interval-dependent differences in Ca2+ transients and contractile responses of diabetic rat cardiomyocytes
Cardiovasc Res, June 1, 2000; 46(3): 450 - 462.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. S Dhalla, X. Liu, V. Panagia, and N. Takeda
Subcellular remodeling and heart dysfunction in chronic diabetes
Cardiovasc Res, November 1, 1998; 40(2): 239 - 247.
[Abstract] [Full Text] [PDF]